Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Director at $ADPT Sells 22,968 Shares

Automated

ROBERT HERSHBERG, a director at $ADPT, sold 22,968 shares of the company on 12-10-2025 for an estimated $367,488. We received data on the trade from a recent SEC filing. This was a sale of approximately 33.0% of their shares of this class of stock. Following this trade, they now own 46,722 shares of this class of $ADPT stock.

$ADPT Insider Trading Activity

ADPT Insider Trades

$ADPT insiders have traded $ADPT stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.

Here’s a breakdown of recent trading of $ADPT stock by insiders over the last 6 months:

  • SHARON BENZENO (Chief Commercial Ofc Imm Med) has made 0 purchases and 3 sales selling 619,006 shares for an estimated $10,356,402.
  • CHAD M ROBINS (CEO and Chairman) has made 0 purchases and 5 sales selling 249,999 shares for an estimated $4,385,926.
  • KYLE PISKEL (Chief Financial Officer) has made 0 purchases and 2 sales selling 163,058 shares for an estimated $3,178,333.
  • HARLAN S ROBINS (Chief Scientific Officer) has made 0 purchases and 3 sales selling 47,212 shares for an estimated $820,715.
  • ROBERT HERSHBERG sold 22,968 shares for an estimated $367,488

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ADPT Hedge Fund Activity

We have seen 145 institutional investors add shares of $ADPT stock to their portfolio, and 129 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ADPT Revenue

ADPT Quarterly Revenue

$ADPT had revenues of $94M in Q3 2025. This is an increase of 102.38% from the same period in the prior year.

You can track ADPT financials on Quiver Quantitative's ADPT stock page.

$ADPT Analyst Ratings

Wall Street analysts have issued reports on $ADPT in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Overweight" rating on 11/06/2025
  • BTIG issued a "Buy" rating on 11/06/2025
  • Piper Sandler issued a "Overweight" rating on 10/15/2025
  • Guggenheim issued a "Buy" rating on 09/30/2025
  • TD Cowen issued a "Buy" rating on 08/06/2025
  • Craig-Hallum issued a "Buy" rating on 06/18/2025

To track analyst ratings and price targets for $ADPT, check out Quiver Quantitative's $ADPT forecast page.

$ADPT Price Targets

Multiple analysts have issued price targets for $ADPT recently. We have seen 8 analysts offer price targets for $ADPT in the last 6 months, with a median target of $18.5.

Here are some recent targets:

  • Tejas Savant from Morgan Stanley set a target price of $16.0 on 11/11/2025
  • Rachel Vatnsdal from JP Morgan set a target price of $20.0 on 11/06/2025
  • Mark Massaro from BTIG set a target price of $21.0 on 11/06/2025
  • David Westenberg from Piper Sandler set a target price of $20.0 on 10/15/2025
  • Subbu Nambi from Guggenheim set a target price of $20.0 on 09/30/2025
  • Dan Brennan from TD Cowen set a target price of $15.0 on 08/06/2025
  • John Wilkin from Craig-Hallum set a target price of $15.0 on 06/18/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles